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Inheritance of Mitochondrial DNA Recombinants
in Double-Heteroplasmic Families: Potential Implications
for Phylogenetic Analysis
Ga´bor Zsurka, Kevin G. Hampel, Tatiana Kudina, Cornelia Kornblum, Yevgenia Kraytsberg,
Christian E. Elger, Konstantin Khrapko, and Wolfram S. Kunz
Recently, somatic recombination of human mitochondrial DNA (mtDNA) was discovered in skeletal muscle. To determine
whether recombinant mtDNA molecules can be transmitted through the germ line, we investigated two families, each
harboring two inherited heteroplasmic mtDNA mutations. Using allele-specific polymerase chain reaction and single-
cell and single-molecule mutational analyses, we discovered, in both families, all four possible allelic combinations of
the two heteroplasmic mutations (tetraplasmy), the hallmark of mtDNA recombination. We strongly suggest that these
recombinant mtDNA molecules were inherited rather than de novo generated somatically, because they (1) are highly
abundant and (2) are present in different tissues of maternally related family members, including young individuals.
Moreover, the comparison of the complete mtDNA sequence of one of the families with database sequences revealed an
irregular, nontreelike pattern of mutations, reminiscent of a reticulation. We therefore propose that certain reticulations
of the human mtDNA phylogenetic tree might be explained by recombination of coexisting mtDNA molecules harboring
multiple mutations.
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Recombination of mtDNA has been described in plants,
fungi, protists, mussels, and fish.1 In human mitochon-
drial genetics, however, the absence of mtDNA recombi-
nation is still a broadly accepted viewpoint.2 The presence
of human mtDNA recombination was initially claimed to
explain the large number of homoplasies in human mtDNA
sequences3 and the results of a linkage-disequilibrium
analysis,4 but the conclusions of the authors could not be
confirmed on different data sets.5,6 More recently, we pro-
vided the first experimental evidence of mtDNA recom-
bination in the skeletal muscle of an individual with bi-
parental inheritance of the mitochondrial genome.7 Fur-
thermore, in a set of skeletal-muscle samples from indi-
viduals with multiple heteroplasmy (who carried a mix-
ture of wild-type and mutated alleles at more than one
location in their mitochondrial genomes), we were able
to show the frequent presence of recombinant mtDNA
molecules.8 However, the relevance of these findings for
mtDNA phylogeny depends on whether human mtDNA
recombination is restricted to skeletal muscle or whether
recombinant mtDNA molecules can enter and pass through
the germ line.
Here, we present experimental data of two double-het-
eroplasmic families, which strongly suggests that recom-
binant mtDNA molecules can be inherited. Furthermore,
one of the investigated families provides an example of
how persisting heteroplasmy and recombination might
explain certain reticulations of the human mtDNA phy-
logenetic tree.
Subjects and Methods
Subjects
The family with the A8344G/A16182C mutations includes a boy,
aged 14 years, who has MERRF syndrome (myoclonus epilepsy
with ragged red fibers [MIM 545000]) and his sister, aged 29 years,
who has occasional seizures. Their parents (and the mother’s sis-
ter) were free of symptoms (fig. 1A). The family with the A3243G/
G16428A mutations includes a man, aged 29 years, who received
the diagnosis of systemic MELAS syndrome (myopathy, enceph-
alopathy, lactic acidosis, and strokelike episodes [MIM 540000]);
his maternal aunt, aged 44 years; and her daughter, aged 12 years
(fig. 2A). The study was conducted following the guidelines of
the University Bonn Ethical Commission, and informed consent
was obtained from all studied subjects.
mtDNA Mutation Analysis
Genomic DNA was extracted from 10-ml aliquots of EDTA-anti-
coagulated blood by use of a salting-out method9 or from frozen
skeletal-muscle or brain-biopsy specimens, buccal swabs, urine
sediment, or cultured fibroblasts with the QiaAmp DNA Mini Kit
(Qiagen). Degrees of heteroplasmy were determined by mismatch
PCR and RFLP analysis. To detect the A8344G MERRF mutation,
primers 5′-GTATTTACCCTATAGCACCCCCTCTAC-3′ (nucleotide
positions [np] 8255–8281 [numbered according to the work of
Anderson et al.10]) and 5′-GGGGCATTTCACTGTAAAGAGGTG-
CCGG-3′ (np 8372–8345) (mismatched positions underlined) were
used, and PCR products were digested with restriction endonu-
clease NaeI. For the MELAS mutation A3243G, primers 5′-GAAAG-
GACAAGAGAAATAAGGCCT-3′ (np 3127–3150) and 5′-GGAATT-
GAACCTCTGACTGTAAAG-3′ (np 3293–3270) and restriction en-
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Figure 1. Family with A8344G and A16182C heteroplasmic mutations. A, Pedigree. The first number indicates the percentage of 8344G;
the second number indicates the percentage of 16182C in blood samples of the family members. B, Apparent cosegregation of the
16182A allele with the 8344G allele in tissue samples of double-heteroplasmic individuals. Mutation loads were determined by RFLP
and were confirmed by sequencing. Circle p blood; square p buccal cells; triangle p urine sediment; diamond p skeletal-muscle
biopsy sample; hexagon p fibroblasts; inverse triangle p brain biopsy sample. Black indicates the sister of the patient’s mother; red
indicates the patient’s mother; white indicates the patient; green indicates the patient’s sister. The 8344G mutant allele primarily co-
occurs with the 16182A wild-type allele (and the 8344A wild-type allele with the D-loop mutant 16182C). A third allelic combination,
the putative “original” wild-type 8344A/16182A, is present in the tissue samples of the sister of the patient’s mother (the data points
are below the line). Data points above the line in the tissue samples of the patient’s sister indicate that 8344G also occurs in combination
with the 16182C allele (the fourth allelic combination, double mutant, and the potential recombinant). C, The recombinant 8344G/
16182C allele, present in the blood of the patient’s mother. Note the faint band indicating the presence of 8344G in the blood of the
patient’s mother, whereas 16182A is virtually absent in this sample (lane 3), which confirms the presence of the recombinant 8344G/
16182C. Lane 1, DNA ladder. Lane 2, Patient’s muscle biopsy (MB) sample. Lane 3, Blood of the patient’s mother (BL). Lane 4, Undigested
PCR product (U). D, Distribution of the two heteroplasmic mtDNA mutations in single fibroblasts of the patient’s sister. Data points
populate all four corners of the graph, which indicates tetraplasmy.
donuclease HaeIII were used; for mutation G16428A, primers 5′-
CCTCCGTGAAATCAATAGCCC-3′ (np 16407–16427) and 5′-CAG-
ATGTCGGATACAGTTCACTT-3′ (np 16503–16481) and restriction
endonuclease Cac8I were used; for mutation A16182C, primers
5′-AAAAACCCAATCCACGTCAA-3′ (np 16162–16181) and 5′-
GTTGGTATCCTAGTGGGTGAG-3′ (np 16282–16262) and restric-
tion endonuclease HincII or primers 5′-AAAAACCCAATCCAC-
ATCCA-3′ (np 16162–16181) and 5′-AGGGGTGGCTTTGGAGTT-
3′ (np 16263–16246) and restriction endonuclease MmeI were
used. Amplification conditions were as follows: at 95C for 5 min;
33 cycles at 95C for 15 s, at 55C or 60C for 30 s, and at 72C
for 1 min; finally, at 72C for 7 min. Restriction fragments were
separated on 10% polyacrylamide gels and were visualized by
SYBR Green I staining (Sigma-Aldrich). Proportions of wild-type
and mutant mtDNA were estimated from band intensities through
use of the ImageJ analysis software.
Allele-specific amplification of DNA fragments carrying either
the wild-type or the mutant allele of np 3243 were performed with
primer 5′-ACCCAATCCACATCAAAACC-3′ (np 16166–16185), to-
gether with either primer 5′-TTAAGTTTTATGCGATTACCGGC-
CT-3′ or primer 5′-TTAAGTTTTATGCGATTACCGGCCC-3′ (np
3267–3243) (mismatched nucleotide underlined; diverging nu-
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Figure 2. Family with A3243G and G16428A heteroplasmic mutations. A, Pedigree. The first number indicates the percentage of 3243G;
the second number indicates the percentage of 16428A in blood samples of the family members. B, Apparent association of the 16428A
allele with the 3243G allele in tissue samples of double-heteroplasmic individuals. The mutation loads were determined by RFLP and
were confirmed by sequencing. Circlep blood; triangle p urine sediment; diamondp skeletal-muscle biopsy sample; inverse triangle
p brain biopsy sample. Black p patient; red p daughter of the patient’s aunt; white p the patient’s aunt. C, Distribution of the
heteroplasmic mutations in different tissue samples from the family members. Note the clear presence of 16428G in the samples of the
patient’s maternal aunt (lane 7). Lane 1, DNA ladder. Lanes 2–5, Patient muscle biopsy (MB) sample, brain (BR), blood (BL), and urine
sediment (UR). Lanes 6–7, Patient’s aunt’s blood (BL) and urine sediment (UR). Lane 8, Patient’s cousin’s blood (BL). Lane 9, Homoplamic
16428A control (C) (isolated PCR fragment). D, Tetraplasmic distribution of the two heteroplasmic mutations, A3243G and G16428A,
in skeletal muscle (MB) and brain (BR) of the patient. Note the presence of both digested and undigested bands in the allele-specific
reaction pairs. The potential recombinant 16428G/3243G is represented by the digested PCR product in the M lanes. Mp mutant 3243G
allele-specific PCR; W p wild-type 3243A allele-specific PCR. T p triplasmic control DNA mixture harboring wild-type, single-mutant
16428A and double-mutant 3243G/16428A mtDNA molecules. E, Tetraplasmy of the A3243G/G16428A alleles in urine sediments from
the patient and his maternal aunt. Note the mtDNA tetraplasmy in both urine sediments, with the potential recombinant 16428G/
3243G (digested PCR product in lanes M). U p undigested PCR product; C p control PCR product with the 16428A mutation.
cleotides in italics). Amplification conditions were as follows: at
96C for 30 s, 20 cycles at 94C for 30 s and at 68C for 8 min,
and finally at 72C for 7 min. One microliter of the amplified
product was used as the template in a second-round mismatch
PCR. Direct sequencing of PCR products was performed on an
automatic sequence analyzer by a commercial sequencing service
(MWG Biotech).
Single-Cell PCR Analysis
A suspension of trypsin-harvested fibroblasts was layered on slides
with poly-L-lysine–treated polyethylene naphtalate membrane and
was incubated at 37C for 2 h, to allow cells to attach to the
membrane. Slides were then immersed sequentially in 70% eth-
anol, 95% ethanol, absolute ethanol, and xylene. Single fibro-
blasts from air-dried membranes were cut using the PALM Micro-
Beam system operating with a nitrogen laser and were catapulted
to a tube cap containing 20 ml magnesium-free PCR buffer, 10-
fold diluted Tris-EDTA buffer, and 0.5% Tween 20. After a short
centrifugation and incubation (for 1 h) at room temperature, sam-
ples were divided into two aliquots and were directly subjected
to mismatch-PCR and RFLP analysis.
Single-Molecule PCR
Individual DNA molecules were amplified using nested PCR un-
der limiting dilution conditions.11 The first 50 cycles of the nested
PCR were performed with forward primer 5′-TAACTCCACCATTA-
GCACCC-3′ (np 15972–15991) and reverse primer 5′-GCTCGCA-
GTGCGCCGATCAGGGCGTAGTTTGAGTTT-3′ (np 3710–3675).
A second round of 15 cycles was made using the inner forward
primer 5′-ACCCAAAGCTAAGATTCTAA-3′ (np 15988–16007) and
the same reverse primer as for the first round. Single-molecule
PCR products were analyzed by HaeIII restriction digestion for
the A3243G mutation. Before digestion, PCR products were con-
verted into homoduplex form by twofold dilution in fresh PCR
mixture and by performing one additional PCR cycle. The G16428A
mutation was determined by direct sequencing of each single-
molecule PCR product.
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Results
Family with the A8344G/A16182C Mutations
In skeletal muscle of a patient harboring the pathogenic
A8344G MERRF mutation, we identified an additional het-
eroplasmic mutation in the noncoding D-loop region at
np 16182. The mutation loads of both heteroplasmic mu-
tations were determined in different available tissue sam-
ples from the patient and family members (fig. 1A) by
RFLP analysis. Additionally, regions of the mitochondrial
genome flanking each mutation were sequenced in each
sample to confirm heteroplasmy and to exclude contam-
ination. Figure 1B shows a combined view of the mutation
loads of both heteroplasmic mutations in all analyzed tis-
sue samples. Data points accumulate mainly in the upper
left corner and in the lower right corner, as well as along
the axis between these two corners. This indicates an abun-
dance of two allelic combinations in the family, 8344A/
16182C (upper left) and 8344G/16182A (lower right). In
all family members, blood samples harbored the most
8344A/16182C alleles, whereas buccal mucosa, urine sedi-
ment, fibroblasts, brain, and skeletal muscle contained in-
creasing amounts of the other alleles, 8344G and 16182A.
However, certain deviations from this approximate dis-
tribution pattern were observed. First, all data points for
the tissue samples from the sister of the patient’s mother
(black symbols in fig. 1B) are located below the theoretical
axis. Such a pattern cannot be interpreted without the
assumption of the presence of the wild-type allelic com-
bination 8344A/16182A. Second, the data points repre-
senting fibroblasts and skeletal muscle from the patient’s
sister (green symbols in fig. 1B) are located above the the-
oretical axis. This can be accomplished only if these sam-
ples harbor the fourth, double-mutant allelic combination
8344G/16182C. Third, when the blood sample from the
patient’s mother was examined in detail, evidence of the
presence of the double-mutant 8344G/16182C combina-
tion was also obtained (fig. 1C; lane 3), since this sample
is apparently homoplasmic for the 16182C allele, whereas
it contains both 8344A and 8344G alleles. In addition to
estimations of bulk tissue-mutation loads, we examined
single fibroblasts of the patient’s sister to find out which
allelic combinations are present in individual cells. Figure
1D shows the distribution of the two heteroplasmic mu-
tations in single fibroblasts. Data points populate all four
corners of the graph, which indicates the presence of all
four possible allelic combinations. Notably, the double-
mutant allelic combination 8344G/16182C (upper right
corner of the graph in fig. 1D) is present in ∼25% of the
cells.
In summary, we observed, in different tissue samples
from the A8344G/A16182C double-heteroplasmic family,
that (1) all four allelic combinations of the two hetero-
plasmic mutations were present in the family, although,
as expected, the distribution showed significant differences
between individuals; (2) two family members carried the
double-mutant (and possibly recombinant) allelic com-
bination; and (3) high amounts of the possibly recombi-
nant genotype, along with all other possible allelic com-
binations, were present in the fibroblast sample from one
individual.
Family with the A3243G/G16428A Mutations
In a second family, we identified the rare G16428A D-loop
mutation in heteroplasmic state in addition to the path-
ogenic A3243G MELAS mutation (fig. 2A). A wide range
of A3243G mutation loads was observed in various tis-
sues of family members (fig. 2B). In contrast, the mutant
16428A allele was in most samples close to homoplasmy;
only the patient’s muscle harbored a high degree of the
wild-type 16428G allele. However, except for the blood
from the daughter of the patient’s aunt, which was appar-
ently homoplasmic 16428A, the presence of the 16428G
allele was confirmed in all other samples (fig. 2C; upper
panel). We examined brain and urine sediment and skel-
etal muscle from the patient and urine sediment from the
patient’s maternal aunt, by a two-round allele-specific/
mismatch PCR approach, to determine which allelic com-
binations were present in these samples. In all investigated
samples, we found that both alleles of G16428A were pre-
sent in combination with both alleles of A3243G, at com-
parable proportions (tetraplasmy) (fig. 2D and 2E). These
findings were confirmed by single-molecule PCR of the
bulk skeletal-muscle sample from the patient. Of 36 mol-
ecules analyzed, 20 were 3243G/16428G, 8 were 3243A/
16428A, 4 were 3243G/16428A, and 4 were 3243A/16428G.
Findings in the family with the A3243G/G16428A mu-
tations, therefore, showed that (1) all four allelic combina-
tions of the two heteroplasmic mutations were present in
two family members and (2) the proportions of the rarer
16428G allele were balanced between both alleles 3243A
and 3243G.
Comparison with Database Sequences
To estimate mutation frequencies and to examine our fam-
ilies in the phylogenetic context, we sequenced the com-
plete mitochondrial genomes of one family member from
each family (GenBank accession numbers DQ862536 [for
the patient with the A3243G/G16428A mutations] and
DQ862537 [for the sister of the patient with the A8344G/
A16182C mutations]) and compared the obtained se-
quences with 11,600 publicly available complete human
mitochondrial genome sequences (GenBank12; mtDB–Hu-
man Mitochondrial Genome Database13).
The A16182C mutation is present in 7.7% of all public-
ly available sequences; however, in most cases, it occurs
along with other mutations as a haplogroup-defining or
a subgroup-defining mutation. In such cases, A16182C is
likely to be acquired once in the respective haplogroup
and to be transferred through maternal lineages rather
than to be generated de novo in each individual. This
assumption is also supported by the study of Meyer et al.,14
who suggested that the mutation rate at position 16182
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Table 1. Frequency of Investigated
Heteroplasmic Mutations in a Collection of
Skeletal-Muscle Biopsies
Mutation
Frequency of
Heteroplasmy in
Skeletal Muscle
(%)
No. of RFLP-Screened
Unrelated Muscle
Samples
A3243G 4.1 266
A8344G 1.1 266
A16182C .4 266
G16428A .5 198
is lower than the average HVRI (hypervariable region I)
mutation rate. Furthermore, the analysis of database se-
quences reveals that the generation of the A16182C mu-
tation is strictly context dependent. The available data
strongly suggest a unidirectional sequence of mutational
events: T16189CrA16183CrA16182C. This chain of
mutation occurs several times in the phylogenetic tree
scattered among different haplogroups. In certain cases,
A16183C and A16182C occur together as haplogroup-de-
fining mutations (e.g., haplogroup T2), whereas, in other
haplogroups, such as haplogroup H, A16183C is present
without the additional appearance of A16182C. Since our
A8344G/A16182C family belongs to haplogroup H (sub-
group H7), the probability of repeated 16182ArC muta-
tional events within this family has to be considered low.
The G16428A mutation occurs twice in the database
(GenBank accession numbers AY339529 and AY339472).
These two database sequences seem to be unrelated, since
they carry only one more common mutation, A16399G,
and 15 and 25 different mutations, respectively. One of
the two database sequences, AY339529, is closely related
to the sequence of our patient, since these two sequences
harbor 20 common mutations and are different at only
two sites.
We strongly suggest that, taken together, neither
G16428A nor A16182C is a mutational hotspot of the
human mitochondrial genome. Since most human mi-
tochondrial sequences in databases were obtained from
blood DNA, we also performed an RFLP screening of our
collection of muscle samples, to exclude the possibility
that nucleotides 16428 and 16182 are tissue-specific mu-
tational hotspots. With this experimental approach, we
were able to detect low levels of heteroplasmy that might
be missed by regular sequencing. The determined allele
frequencies shown in table 1 prove that heteroplasmy at
these particular D-loop sites is very rare.
Discussion
To address the question of whether recombinant mtDNA
molecules can be inherited, we examined families harbor-
ing two heteroplasmic mutations in several family mem-
bers. In each investigated family, one heteroplasmic mu-
tation was a well-characterized pathogenic mutation in
the coding region, whereas the other heteroplasmic mu-
tation was located in the noncoding D-loop region. The
two heteroplasmic mutations were separated by several
thousand nucleotides in both families, leaving enough
distance for possible recombination events.8 To conclude
inheritance of recombinant mtDNA molecules, the follow-
ing questions have to be addressed. (1) Are all four possible
combinations of the two heteroplasmic alleles present in
the family? Two sequentially occurring independent mu-
tation events would create a mixture of only three geno-
types (triplasmy). For the creation of all four genotypes
(tetraplasmy), either recurrent mutation events or recom-
bination is required. (2) How high is the probability that
a specific mutational event occurs repeatedly in an indi-
vidual or in a family? Such recurrent mutations would also
have a chance to create tetraplasmy, a pattern that is sim-
ilar to the outcome of recombination. (3) Can recombi-
nant mtDNA molecules be observed in different family
members? If yes, are they likely to be results of indepen-
dent recombination events or, rather, transmitted through
the germ line?
Elsewhere, we addressed the first two questions in the
study of skeletal muscle of double-heteroplasmic individ-
uals,8 and we showed that tetraplasmy was present in cases
where the probability of recurrent mutations was negli-
gible. We interpreted this finding as a sign of recombi-
nation of the human mitochondrial genome. Apart from
addressing the same questions in new cases and other tis-
sues, here, we extend our investigations to the family level
to evaluate the potential impact of mtDNA recombination
on mtDNA phylogeny.
We demonstrate in this study that individuals of both
investigated families harbor all four possible allelic com-
binations of the two heteroplasmic mutations. This ap-
proach is analogous to the “four-gamete” test found in
the classic literature about DNA recombination.15 The two
pathogenic heteroplasmic mutations investigated here,
A3243G (MELAS) and A8344G (MERRF), are rare (see table
1), and they have been recognized as having the potential
to be inherited through several generations. Recent reports
provided evidence that long-persisting heteroplasmy ap-
pears to not be an exclusive feature of certain pathogenic
mutations; rather, it is also a feature of D-loop polymor-
phisms.16,17 Whether two heteroplasmic instances of a spe-
cific mtDNA mutation occurred independently or are re-
lated (i.e., originate from a single mutation event and have
been inherited in the heteroplasmic state) may be difficult
to distinguish. Since members of the published families16,17
carry heteroplasmy at the same site, inheritance of het-
eroplasmy in these families is more plausible, unless one
assumes a family-specific and site-specific instability of
the mitochondrial genome. In respect to the both D-loop
sites—A16182C and G16428A—investigated in our report,
we conclude from comparison with database sequences
and a screening of a large collection of brain and muscle
sample that heteroplasmy at these sites is rare. Therefore,
similar to the pathogenic mutations A3243G and A8344G,
the D-loop mutations A16182C and G16428A are likely to
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Figure 3. Schematic representation of different theoretical sce-
narios that result in reticulation. A, Standard phylogenetic tree.
Two sequential mutations create three different types of genomes
(no reticulation). In some cases, all four possible combinations
of the two mutations are present in a population (B). Then they
have to be formally related by a nontree network structure (retic-
ulation). The square-shaped reticulations can be easily recognized
within typical mtDNA phylogenetic trees.19,20 Reticulations are usu-
ally “resolved” into tree structures by the assumption of either
recurrent mutations (C) or reverse mutations (D). We propose that,
alternatively, reticulations can result from recombination of mtDNA
in double-heteroplasmic individuals (E). The persistent hetero-
plasmy (double line) is switched to a triplasmic double-hetero-
plasmic state (triple line) by a second mutational event. Recom-
bination can then create the fourth allelic combination that leads
to reticulation.
originate from single mutation events within the respec-
tive families. Since recurrence of mutational events has
such a low probability, we conclude that the tetraplasmy
observed in the study individuals indicates recombination
of the mitochondrial genome.
The limited number of published cases in which recom-
bination might contribute to the allelic distribution of
heteroplasmic mitochondrial mutations makes it impos-
sible to estimate the frequency of recombination events
in humans. The reported proportions of putative recom-
binant genotypes highly diverge between individuals and
have probably only a limited conclusive value concern-
ing frequency of recombination. Similar to genomes with
newly obtained mutations, recombinant mtDNA mole-
cules are likely to be subjects of major segregational prop-
agation or extinction. When segregational drifts are taken
into account, it is more plausible to assume that recom-
binant mtDNA molecules were transmitted through the
germ line rather than repeatedly generated in somatic cells
(1) if recombinant molecules represent a large portion of
all mitochondrial genomes in tissues and especially if this
can be observed in young individuals, (2) if recombinant
molecules not only appear in isolated tissues but are pre-
sent in the whole body, and (3) if recombinant genotypes
are detectable in different members of a family. Both fam-
ilies investigated here fulfill all three criteria. In all sam-
ples in which genotype frequencies were determined ex-
perimentally, all four allelic combinations were present at
considerable levels. Since earlier observations indicate a
rather low frequency of somatic recombination,7 our data
strongly suggest the inheritance of the recombinant mi-
tochondrial genotypes, even in the absence of direct evi-
dence of recombinant mtDNA in female germ cells.
Interestingly, the mitochondrial genome of the pa-
tient with the A3243G/G16428A mutation appears to be
closely related to a database sequence that also carries the
G16428A mutation (AY339529).18 These two sequences are
identical, with the exceptions that the mutation A249G,
which is present in the database sequence, is missing from
our patient, whereas the C150T mutation can be found
in our patient and not in AY339529. Furthermore, an ad-
ditional sequence (AY339528)18 is present in the database
that harbors all mutations common between our patient
and AY339529 but does not carry G16428A and harbors
A249G. Thus, the two mutations A249G and G16428A
create a remarkable pattern in this small subgroup of three
individuals: each mutation is missing from one of the
three individuals. Their phylogenetic relationship can be
described only by a network. Similar deviations from the
standard tree structure—called “reticulations”—are rela-
tively common in mtDNA phylogenetic trees19,20 and al-
ways represent a serious problem for tree reconstruction
and interpretation. Traditional explanations for reticula-
tion include recurrent mutations at group-specific hot-
spots and reverse mutations, but recombination has also
been suggested to create reticulations.3,21
A schematic view of possible mutation events that lead
to a reticulation is shown in figure 3. Normally, two se-
quential mutational events create three types of genomes
(fig. 3A). In the event of a reticulation (fig. 3B), four ge-
nome types are present. One possible explanation is that
one of the reticulating mutations happens more than once
in the specific subgroup, which creates all possible al-
lelic combinations (fig. 3C). However, it is difficult to
explain why a specific site mutates repeatedly in a very
small subgroup when the same site shows very high sta-
bility throughout the entire human population. Haplo-
group-specific changes in mutation rates of specific mtDNA
sites have been proposed,16,22 but the the smaller the re-
ticulating group is and the rarer the reticulating mutations
are in the general population, the more dramatic the
changes of mutation rates have to be assumed. Another
explanation of reticulations postulates that a second mu-
tation makes a previously mutated site unstable, so that
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it “mutates back” to wild type (fig. 3D). This scenario
would, however, create a mutational drift toward the wild
type, thus eliminating the mutant at the phylogenic scale,
which appears to contradict statistical observations.21 Fur-
thermore, for both reverse and recurrent mutations (with
the exception of simple repeats23), no molecular mecha-
nism is known at present that could explain the large
variations of mutation rates.2
We propose an alternative mechanism that does not re-
quire site-specific or group-specific molecular mechanisms
to explain a reticulation. As shown in figure 3E, the re-
combination of coexisting heteroplasmic mutations (in-
dicated by double or triple lines) creates a reticulating pat-
tern. This scenario is possible only if a newly generated
mtDNA mutation persists in the heteroplasmic state until
a second mutation occurs, so that the two heteroplasmic
mutations coexist within an individual, which permits
productive recombination. Coexistence of heteroplasmic
mutations has been already demonstrated in several pub-
lished examples.8,16,17,24–26
To summarize, our findings strongly suggest that recom-
bination of the human mtDNA is not restricted to somatic
tissues; rather, recombinant mtDNA molecules can be trans-
mitted through the germ line. This feature could explain
the presence of certain allelic combinations in maternal
lineages that cannot be inferred from a plain sequential
order of mutational events. Thus, our hypothesis—that
recombination of coexisting heteroplasmic mutations cre-
ates reticulations—eliminates the need to search specific
molecular mechanisms for an explanation of individual
reticulations in the human mtDNA phylogenetic tree.
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mtDB–Human Mitochondrial Genome Database, http://www
.genpat.uu.se/mtDB/
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim/ (for MERRF syndrome and MELAS
syndrome)
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